Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Dundee Corp T.DC.A

Alternate Symbol(s):  DDEJF

Financial Services Healthcare Technology Asset Management Gold Silver
Dundee Corporation is a Canada-based holding company. Through its operating segments, the Company is a mining- focused investor primarily engaged in acquiring mineral resource assets. Its segments include mining investments, mining services, and corporate and others. Its asset base includes investments in precious and base metals projects across four continents. Its subsidiaries include Dundee... see more

TSX:DC.A - Post Discussion

Dundee Corp > TaurX
View:
Post by valueinvestor89 on May 26, 2022 2:15pm

TaurX

https://www.prnewswire.com/in/news-releases/taurx-s-late-stage-clinical-trial-reaches-new-milestone-893482727.htmltaurx press release here

We should expect some big news in the next few days with regards to the phase 3 trials of TaurX (alzheimer's cure/delay). The carrying value is $35m and it owns about 4% of the company. 

The top line results of the trial come out at the end of may which will give us a good idea if the investment is worth $400m or 0 at our share. in 2016 the thought were that Taurx will IPO at $15bn USD so the $400m i made up for illustrative purposes is based on an $8bn valuation or half of the original expectations.

Worth adding units in my opinion now as i've always internally carried TaurX as 0 and can participate in the upside if the results are positive.
Comment by Catscratch on May 26, 2022 7:37pm
DC.A's share price is reflecting no value for Taurx so I think it's a heads you win / tails your don't lose, situation. Fingers crossed for some positive results but not holding my breath.
Dundee Corp
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities